Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$28.6M
+13.5% from 2023
Prescriptions
704
$40,574.20 per claim
Patients
71
77 prescribers
Total spending, 2024
$28.6M
$402,313.23 per patient
Medicare prescription drug plans paid $28.6M for Empaveli in 2024, for 704 prescriptions and refills to 71 patients (up 13.5% from 2023). The average cost per claim was $40,574.20.
North Carolina had the highest Medicare cost for Empaveli in 2024: $3.2M for 77 claims, followed by Florida ($2.8M).
Sendhilnathan Ramalingam, hematology-oncology in Durham, NC, had the highest Medicare cost for Empaveli in 2024: 26 claims costing $1.1M.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sendhilnathan Ramalingam Durham, NC | Hematology-Oncology | 26 | Under 11 | $1.1M |
| Hilary Gomolin Delray Beach, FL | Hematology-Oncology | 21 | Under 11 | $946K |
| Michael J Stanek |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 52 | 438 | 49 | $16.5M |
| 2023 | 73 | 657 | 68 | $25.2M |
| 2024 | 77 | 704 | 71 | $28.6M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 24 |
| Under 11 |
| $918K |
| Timothy E Kubal Tampa, FL | Hematology-Oncology | 14 | Under 11 | $824K |
| Marshall A Mazepa Minneapolis, MN | Hematology-Oncology | 13 | Under 11 | $690K |
| Carlos M Decastro III Durham, NC | Hematology-Oncology | 13 | Under 11 | $615K |
| Randy R Calegari Las Vegas, NV | Hematology-Oncology | 14 | Under 11 | $557K |
| Sumithira Vasu Columbus, OH | Hematopoietic Cell Transplantation and Cellular Therapy | 14 | Under 11 | $540K |
| Molly M Daughety Portland, OR | Internal Medicine | 13 | Under 11 | $539K |
| Richard R Furman New York, NY | Medical Oncology | 14 | Under 11 | $530K |
| Jonathan K Levine Charlotte, NC | Hematology-Oncology | 13 | Under 11 | $522K |
| Christopher B Benton Englewood, CO | Medical Oncology | 13 | Under 11 | $522K |
| Muhammad F Iqbal Palm Coast, FL | Hematology-Oncology | 13 | Under 11 | $522K |
| Michael Porubcin Moline, IL | Hematology-Oncology | 13 | Under 11 | $521K |
| Rex B Mowat Toledo, OH | Hematology-Oncology | 11 | Under 11 | $521K |
| Adarsh M Hiremath Gastonia, NC | Hematology-Oncology | 13 | Under 11 | $521K |
| Jaroslaw P Maciejewski Cleveland, OH | Hematology-Oncology | 12 | Under 11 | $507K |
| Craig S Boddy Honolulu, HI | Hematology-Oncology | 13 | Under 11 | $501K |
| Courtney M Bellomo Albany, NY | Medical Oncology | 13 | Under 11 | $498K |
| Joshua J Field Milwaukee, WI | Hematology-Oncology | 13 | Under 11 | $498K |
| Kuang S Chang Athens, GA | Hematology-Oncology | 13 | Under 11 | $498K |
| Marc E Usrey Tyler, TX | Hematology-Oncology | 13 | Under 11 | $492K |
| Lewis J Rose Philadelphia, PA | Hematology-Oncology | 13 | Under 11 | $492K |
| Candido E Rivera-Linares Jacksonville, FL | Hematology-Oncology | 13 | Under 11 | $492K |
| Ayman Qasrawi Lexington, KY | Hematology-Oncology | 13 | Under 11 | $492K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Apellis Pharmac | 704 | $28.6M |